Quantcast

Latest Aeras Stories

2014-09-15 20:22:06

Seven New Grant Investments for $15.3 Million to Tackle Malaria, Chagas Disease and Dengue, which is Dramatically on the Rise TOKYO, Sept. 15, 2014 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle...

2014-04-23 16:29:39

STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial. The announcement by Bill Gates, co-chair of the Bill...

2014-03-24 12:29:41

Aeras releases TB Crisis Tracker on World TB Day ROCKVILLE, Md., March 24, 2014 /PRNewswire/ -- The tuberculosis epidemic continues to impact pockets of the U.S. population, according to a data visualization tool developed by the nonprofit biotech, Aeras. Launched on World TB Day, Aeras's TB Crisis Tracker illustrates how the TB epidemic continues to impact the U.S. "TB's impact in the U.S. is but a fraction of what it once was, but the Aeras TB Crisis Tracker starkly...

2013-11-18 23:21:06

Reportbuyer.com just published a new market research report: Tuberculosis Global Clinical Trials Review, H2, 2013. (PRWEB) November 18, 2013 Summary GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H2, 2013" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per...

Tuberculosis Vaccine Shows Promising Results
2013-10-03 04:39:56

redOrbit Staff & Wire Reports - Your Universe Online Canadian researchers have developed a new tuberculosis vaccine that could boost or perhaps replace the only existing way to immunize against the infection. The researchers say the new vaccine is an important breakthrough because the current tuberculosis vaccine is not effective enough to curb the TB epidemic in some parts of the world. "We are the first to have developed such a vaccine for tuberculosis," said Dr. Fiona Smaill,...

Tuberculosis Vaccine Fails Infant Trial
2013-02-04 14:42:30

[ Watch the Video: Discussing New Tuberculosis Vaccine Trials ] Lee Rannals for redOrbit.com - Your Universe Online A new vaccine considered to be the most advanced for tuberculosis (TB) among more than a dozen now in trials has failed its study. Researchers said they were disappointed by the results of the study, which showed that the vaccine offered little to no protection at all from TB. Nearly 3,000 babies in South Africa took part in the study, all of whom had already been...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'